Marijuana reduces tobacco use

Study: Cannabis Compound Reduces Cigarette Consumption In Tobacco Smokers

The inhalation of the non-psychoactive cannabinoid CBD (cannabidiol) significantly mitigates tobacco smokers’ desire for cigarettes, according to clinical trial data published online in the journal Addictive Behaviors. Investigators concluded, “This is the first study, as far as we are aware, to demonstrate the impact of CBD on cigarette smoking. … These preliminary data, combined with the strong preclinical rationale for use of this compound, suggest CBD to be a potential treatment for nicotine addiction that warrants further exploration.”

Image includes a leafy cannabis plant, the structural formula for THC and for CBD, and icons representing clinical applications for cannabis, like sleep and pain

Even More Science Suggesting That Cannabinoids May Halt Diabetes

Preclinical study data published online in the scientific journal Nutrition & Diabetes reports that tetrahydrocannabivarin (THCV) — a naturally occurring analogue of THC — possesses positive metabolic effects in animal models of obesity. Researchers concluded: “Based on these data, it can be suggested that THCV may be useful for the treatment of the metabolic syndrome and/or type 2 diabetes (adult onset diabetes), either alone or in combination with existing treatments.”

A droplet of oils drips from the medicine dropper over a bottle of cannabis oil next to a marijuana plant

Study: Hemp Seed Oil Associated With Improved Clinical and Immunological Parameters In Multiple Sclerosis Patients

The consumption of legal hemp seed nutritional oil, in conjunction with the intake of evening primrose oils and a restrictive diet high in Hot-natured foods (such as pepper) and low in saturated fats and sugars, is associated with “significant improvement” in symptom management and immunological characteristics in subjects with multiple sclerosis, according to clinical trial data published this month in the scientific journal BioImpacts.